NEURONA THERAPEUTICS

neurona-therapeutics-logo

Neurona Therapeutics is a pre-clinical stage biotechnology company that was founded by four neuroscientists and stem cell pioneers at The University of California, San Francisco. They are focused on the discovery and development of cell-based therapies to treat intractable neurological disease. Its initial aim is to generate therapeutic compositions of a specific type of nerve cell (or neuron) for targeted delivery into the injured nervous system. Based on nearly two decades of research, they believe that particular subpopulations of neurons have the unique ability to integrate and repair dysregulated neural circuits. Its talented team of scientists, scientific advisors, and board directors is working to accelerate breakthrough treatments for patients with significant unmet medical needs.

#SimilarOrganizations #People #Financial #Website #More

NEURONA THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Therapeutics

Founded:
2008-04-01

Address:
San Francisco, California, United States

Country:
United States

Website Url:
http://www.neuronatherapeutics.com

Total Employee:
51+

Status:
Active

Contact:
(650) 799-6465

Total Funding:
156.63 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Analytics LetsEncrypt Google Tag Manager Apache Global Site Tag Google Maps US Privacy User Signal Mechanism


Similar Organizations

acrivon-therapeutics-logo

Acrivon Therapeutics

Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.

akebia-therapeutics-logo

Akebia Therapeutics

Akebia Therapeutics develops treatments for ischemia and vascular diseases.

autobahn-therapeutics-logo

Autobahn Therapeutics

Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.

excision-biotherapeutics-logo

Excision BioTherapeutics

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

fulcrum-therapeutics-logo

Fulcrum Therapeutics

Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.

lucy-therapeutics-logo

Lucy Therapeutics

Lucy Therapeutics is a biotech company providing effective treatments for neurological diseases start with the mitochondria.


Current Advisors List

erica-whittaker_image

Erica Whittaker Board Member @ Neurona Therapeutics
Board_member
2021-06-01

arnold-kriegstein_image

Arnold Kriegstein Scientific Advisor @ Neurona Therapeutics
Advisor

Current Employees Featured

cory-r-nicholas_image

Cory R. Nicholas
Cory R. Nicholas Co-Founder & CEO @ Neurona Therapeutics
Co-Founder & CEO
2019-01-01

tim-kutzkey_image

Tim Kutzkey
Tim Kutzkey CEO @ Neurona Therapeutics
CEO

not_available_image

Gautam Banik
Gautam Banik Chief Technology Officer @ Neurona Therapeutics
Chief Technology Officer
2021-12-01

arnold-kriegstein_image

Arnold Kriegstein
Arnold Kriegstein Co-Founder @ Neurona Therapeutics
Co-Founder

Founder


arnold-kriegstein_image

Arnold Kriegstein

cory-r-nicholas_image

Cory R. Nicholas

Investors List

california-institute-of-regenerative-medicine-cirm_image

California Institute of Regenerative Medicine (CIRM)

California Institute of Regenerative Medicine (CIRM) investment in Grant - Neurona Therapeutics

sphera-funds-management_image

Sphera Funds Management

Sphera Funds Management investment in Venture Round - Neurona Therapeutics

alexandria-venture-investments_image

Alexandria Venture Investments

Alexandria Venture Investments investment in Venture Round - Neurona Therapeutics

the-column-group_image

The Column Group

The Column Group investment in Venture Round - Neurona Therapeutics

ucb-ventures_image

UCB Ventures

UCB Ventures investment in Venture Round - Neurona Therapeutics

ironfire-capital_image

Ironfire Ventures

Ironfire Ventures investment in Venture Round - Neurona Therapeutics

south-carolina-research-authority_image

South Carolina Research Authority

South Carolina Research Authority investment in Grant - Neurona Therapeutics

national-institutes-of-health_image

National Institutes of Health

National Institutes of Health investment in Grant - Neurona Therapeutics

the-column-group_image

The Column Group

The Column Group investment in Series A - Neurona Therapeutics

alexsis-de-raadt-st-james_image

Alexsis de Raadt-St. James

Alexsis de Raadt-St. James investment in Series A - Neurona Therapeutics

Official Site Inspections

http://www.neuronatherapeutics.com Semrush global rank: 2.38 M Semrush visits lastest month: 7.75 K

  • Host name: ec2-34-192-255-123.compute-1.amazonaws.com
  • IP address: 34.192.255.123
  • Location: Ashburn United States
  • Latitude: 39.0481
  • Longitude: -77.4728
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20149

Loading ...

More informations about "Neurona Therapeutics"

Neurona Therapeutics | NRTX-1001 Inhibitory Neuron Cell …

Neurona is developing allogeneic, off-the-shelf neural cell therapies for multiple chronic neurological disorders. The pipeline includes neuronal, glial, and gene-edited cell therapy …See details»

Mission | Leadership | Investors | Neurona Therapeutics

Neurona was founded by leading-edge neuroscientists and stem cell pioneers at the University of California, San Francisco. Based on nearly two decades of research, we believe that specific …See details»

Careers and Values - Neurona Therapeutics

At Neurona we have a bold vision to create novel regenerative cell therapies that have the potential to profoundly improve the quality of life for people suffering from chronic neurologic disorders.See details»

Neurona Therapeutics - LinkedIn

Neurona is a biotherapeutics company developing neural cell therapies with single-dose curative potential for the treatment of chronic neurological disorders.See details»

Neurona Therapeutics - Crunchbase Company …

Neurona Therapeutics is a pre-clinical stage biotechnology company that was founded by four neuroscientists and stem cell pioneers at The University of California, San Francisco. They are focused on the discovery and …See details»

A Conversation with CEO Cory Nicholas on …

Aug 15, 2024 · Our work at Neurona Therapeutics focuses on the development of allogeneic, or off-the-shelf, regenerative cell therapies, meaning therapies that are manufactured from a single cell source for all patients eligible to receive them.See details»

Neurona Therapeutics Raises $120M to Advance …

Feb 9, 2024 · Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapy candidates for the treatment of neurological disorders, today announced the successful completion of a $120 million …See details»

Neurona Therapeutics Company Profile 2024: Valuation, …

Operator of a clinical-stage biotherapeutics company intended to develop regenerative neural cell therapies with single-dose curative potential for the treatment of chronic neurological disorders.See details»

Neurona Therapeutics Raises $41.5M to Advance Neural …

SAN FRANCISCO, June 22, 2021 (GLOBE NEWSWIRE) -- Neurona Therapeutics Inc., a biotherapeutics company developing neural cell therapies for the treatment of chronic …See details»

Regenerative Pluripotent Stem Cell Technology

Neurona’s discovery platform is powered by regenerative pluripotent stem cell technology and used to develop proprietary manufacturing processes that produce authentic neural cell therapy candidates. The company’s wholly …See details»

Neurona Therapeutics Announces FDA Clearance of …

Feb 14, 2023 · NRTX-1001 administration is well-tolerated and shows seizure reduction of >90% in the first two patients at six- and three-months post-treatment, respectively. Data & Safety …See details»

Neurona Therapeutics Presents Preclinical Data from Lead …

Nov 8, 2021 · IND cleared by the FDA to enable initiation of Phase 1/2 clinical trial of NRTX-1001 in people with drug-resistant focal epilepsy. Supporting preclinical data demonstrate seizure …See details»

Neurona Therapeutics Raises $120M to Advance …

Feb 8, 2024 · “Neurona has pioneered development of a fully-differentiated cell therapy for drug-resistant focal epilepsy that is designed to be disease-modifying, repairing the affected neural …See details»

Neurona Therapeutics Inc. - VentureRadar

Website: http://www.neuronatherapeutics.com/ Develops regenerative cell therapies to repair neural circuits in chronic neurological disorders, offering potential single-dose curative …See details»

Neurona Therapeutics Presents One-Year Data on the …

Jun 15, 2023 · Promising reduction (>95%) in seizure frequency at the key one-year post treatment endpoint in the first patient to receive NRTX-1001, memory improvements, and …See details»

Latest News and Events for Neurona Therapeutics

Mar 29, 2024 · Latest News and Events for Neurona Therapeutics; a clinical-stage company focused on discovering and developing allogeneic neural cell therapies to treat chronic …See details»

Neurona raises another $120M for brain disease cell therapies

Feb 8, 2024 · Neurona Therapeutics, a San Francisco-based biotechnology company, has raised another $120 million to fuel its research into cell therapies for brain diseases. Neurona plans to …See details»

Neurona Therapeutics Raises $41.5M to Advance Neural …

San Francisco, CA, June 22, 2021 – Neurona Therapeutics Inc., a biotherapeutics company developing neural cell therapies for the treatment of chronic neurological disorders, today …See details»

Neurona Therapeutics Receives IND Clearance to Initiate

SAN FRANCISCO, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Neurona Therapeutics, a biotherapeutics company advancing restorative neural cell therapies for the treatment of …See details»

Neurona Therapeutics - Overview, News & Similar …

May 12, 2024 · View Neurona Therapeutics (www.neuronatherapeutics.com) location in Greater London, United Kingdom , revenue, industry and description. Find related and similar …See details»

linkstock.net © 2022. All rights reserved